CDK6, a new target in MLL-driven leukemia
- PMID: 24993876
- DOI: 10.1182/blood-2014-05-572917
CDK6, a new target in MLL-driven leukemia
Abstract
In this issue of Blood, Placke et al identify the cell-cycle regulator CDK6 as a promising new target in mixed lineage leukemia (MLL)-rearranged acute myeloid leukemia (AML) and show that its downregulation or pharmacological inhibition leads to growth inhibition and differentiation of MLL-driven leukemic cells.
Comment on
-
Requirement for CDK6 in MLL-rearranged acute myeloid leukemia.Blood. 2014 Jul 3;124(1):13-23. doi: 10.1182/blood-2014-02-558114. Epub 2014 Apr 24. Blood. 2014. PMID: 24764564 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical

